Sobi is an international rare disease company dedicated to providing access to innovative treatments that make a significant difference for people with rare diseases. We have two business areas: Haemophilia and Specialty Care. Our research and product portfolio is primarily focused on haemophilia, inflammation, and genetic and metabolic diseases.
The United Kingdom and Republic of Ireland team is based in Cambridge and have been rated as the best company in Haemophilia in the UK through an annual independent survey in 2016, 2017 and 2018 (1st, 1st & 2nd), a centre of excellence for wellbeing in 2018 and one of the UK’s great places to work in 2017, 2018 and 2019. Sobi’s website.